IRIS
Narcisi, Alessandra
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.170
NA - Nord America 1.839
SA - Sud America 982
EU - Europa 490
AF - Africa 84
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 3
AN - Antartide 1
Totale 5.575
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.754
SG - Singapore 1.223
BR - Brasile 811
CN - Cina 390
VN - Vietnam 336
IT - Italia 79
AR - Argentina 77
FI - Finlandia 71
IE - Irlanda 65
EC - Ecuador 41
HK - Hong Kong 41
GB - Regno Unito 38
CA - Canada 37
DE - Germania 37
MX - Messico 36
ID - Indonesia 34
IN - India 34
FR - Francia 33
RU - Federazione Russa 29
NG - Nigeria 27
NL - Olanda 24
SE - Svezia 23
BE - Belgio 21
ZA - Sudafrica 21
BD - Bangladesh 20
CO - Colombia 16
JP - Giappone 16
UA - Ucraina 16
TR - Turchia 12
ES - Italia 11
PK - Pakistan 11
PL - Polonia 11
IQ - Iraq 10
PE - Perù 9
PY - Paraguay 9
MA - Marocco 8
TN - Tunisia 8
VE - Venezuela 8
UZ - Uzbekistan 6
XK - ???statistics.table.value.countryCode.XK??? 6
CL - Cile 5
KE - Kenya 5
EG - Egitto 4
KZ - Kazakistan 4
LT - Lituania 4
UY - Uruguay 4
AL - Albania 3
AU - Australia 3
BH - Bahrain 3
CZ - Repubblica Ceca 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
GE - Georgia 3
KG - Kirghizistan 3
LV - Lettonia 3
NP - Nepal 3
PA - Panama 3
AT - Austria 2
AZ - Azerbaigian 2
BG - Bulgaria 2
EE - Estonia 2
ET - Etiopia 2
HN - Honduras 2
IL - Israele 2
MT - Malta 2
OM - Oman 2
PH - Filippine 2
PS - Palestinian Territory 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CH - Svizzera 1
DK - Danimarca 1
GN - Guinea 1
GP - Guadalupe 1
GT - Guatemala 1
HU - Ungheria 1
JO - Giordania 1
KW - Kuwait 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LY - Libia 1
MD - Moldavia 1
MK - Macedonia 1
ML - Mali 1
MY - Malesia 1
PT - Portogallo 1
QA - Qatar 1
RO - Romania 1
SN - Senegal 1
SO - Somalia 1
SR - Suriname 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
Totale 5.574
Salva come PNG Salva come JPEG
Città #
Chandler 245
Singapore 243
Shanghai 203
Dallas 171
The Dalles 163
Ashburn 147
Ho Chi Minh City 123
Beijing 120
Boardman 89
Wilmington 86
Helsinki 71
New York 67
Dublin 64
São Paulo 61
Hanoi 55
San Mateo 45
Hong Kong 40
Los Angeles 36
Ann Arbor 34
Lawrence 34
Princeton 34
Milan 32
Benin City 27
Rio de Janeiro 25
Santa Clara 23
Brussels 21
Paris 20
Brooklyn 19
Haiphong 19
Phoenix 17
Guayaquil 16
Belo Horizonte 15
Mexico City 15
Seattle 15
Tokyo 15
Da Nang 14
Leawood 14
Amsterdam 13
Can Tho 12
Curitiba 12
Hải Dương 12
Johannesburg 12
London 12
Buenos Aires 11
Chicago 11
Brasília 10
Council Bluffs 10
Fairfield 10
Montreal 10
Salvador 10
Warsaw 10
Quito 9
Chennai 8
Dronten 8
Jakarta 8
Phủ Lý 8
Porto Alegre 8
São Bernardo do Campo 8
Bauru 7
Boston 7
Campinas 7
Goiânia 7
Lima 7
Munich 7
Ninh Bình 7
Poplar 7
Recife 7
San Francisco 7
Sorocaba 7
Teresina 7
Toronto 7
Assago 6
Bắc Giang 6
Charlotte 6
New Delhi 6
Orem 6
Osasco 6
Sumaré 6
Tashkent 6
Thái Bình 6
Uberlândia 6
Woodbridge 6
Anápolis 5
Asunción 5
Atlanta 5
Belém 5
Caraguatatuba 5
Contagem 5
Dhaka 5
Guarulhos 5
Lấp Vò 5
Moscow 5
Nairobi 5
Naples 5
Ourinhos 5
Praia Grande 5
Tunis 5
Vitória 5
Biên Hòa 4
Cape Town 4
Totale 2.895
Salva come PNG Salva come JPEG
Nome #
Melanoma in Adolescents and Young Adults (AYAs): An Italian Multi-Centric Retrospective Experience 186
Chronic Hand Eczema (CHE): A Narrative Review 104
Brodalumab: a new way to inhibit IL-17 in psoriasis 90
Specific Infiltrate of Hodgkin Lymphoma at Site of Cellulitis Mimicking Secondary Cutaneous Involvement 78
A fatal case of COVID-19 infection presenting with an erythema multiforme-like eruption and fever 77
Clinical course of COVID-19 in 41 patients with immune-mediated inflammatory diseases: Experience from humanitas center, Milan 69
Anti-IL17 and anti-IL23 biologic drugs for scalp psoriasis: A single-center retrospective comparative study 69
Programmed cell death in the skin 66
S100A8/A9 in psoriatic plaques from patients with psoriatic arthritis 66
Psychiatric comorbidity and suicidal ideation in psoriasis, melanoma and allergic disorders 65
Biologic therapies for plaque type psoriasis in patients with previous malignant cancer: long-term safety in a single- center real-life population 65
Long-term treatment with adalimumab in psoriatic arthritis: serum adalimumab concentration, immunogenicity and the link with clinical response 64
Use of biological drugs in patients with psoriasis and psoriatic arthritis in Italy: Results from the PSONG survey 63
Apremilast for the treatment of palmo-plantar non-pustular psoriasis: A real-life single-center retrospective study 63
Real-life Effectiveness and Safety of Risankizumab in Moderate-to-severe Plaque Psoriasis: A 40-week Multicentric Retrospective Study 60
Long-term safety of etanercept in psoriasis: Retrospective study focused on infections 58
25-Hydroxyvitamin D serum levels and melanoma risk: a case-control study and evidence synthesis of clinical epidemiological studies 58
A real-world economic analysis of biologic therapies for moderate-to-severe plaque psoriasis in Italy: results of the CANOVA observational longitudinal study 57
Long-term safety and efficacy of adalimumab in psoriasis: a multicentric study focused on infections (connecting study) 57
Effects of TNF-α inhibition on pre-clinical enthesitis: observational study on 49 psoriatic patients 56
Complicated coronavirus disease 2019 (COVID-19) in a psoriatic patient treated with ixekizumab 55
Measuring psoriatic disease in clinical practice. An expert opinion position paper 55
Palmar nodules in a young woman with ulcerative colitis and enteropathic arthritis 54
Reorganization of a Northern Italy dermatology department during the COVID-19 pandemic: is it temporary or the beginning of a new era in dermatology? 53
noveaux horizon therapeutiques pour le prurit dermatologique au delà de la dermatite atopique: role de i-modulia 52
A severe psoriasis flare after COVID-19 treated with risankizumab: complete skin clearance after 16 weeks 51
Impact of delay in follow-up due to COVID-19 pandemic on skin cancer progression: a real-life experience from an Italian hub hospital 51
Diagnostic imaging: Listening in to skin disease 50
TP63 and TP73 in cancer, an unresolved "family" puzzle of complexity, redundancy and hierarchy. 49
Generalized pustular psoriasis flare in a patient affected by plaque psoriasis after BNT162b2 mRNA COVID-19 vaccine, successfully treated with risankizumab 48
Non-complicated evolution of COVID-19 infection in a patient with psoriasis and psoriatic arthritis during treatment with adalimumab 48
Concomitant Pyoderma Gangrenosum-like and Amicrobial Pustulosis of the Folds: a Case Report 48
A 3-Year Multicentric Study on Switching from Ustekinumab to Guselkumab in Partial Responders with Psoriasis—IL PSO (Italian Landscape Psoriasis) 47
A risankizumab super responder profile identified by long-term real-life observation-IL PSO (ITALIAN LANDSCAPE PSORIASIS) 46
Urticarial rash in autoinflammatory syndromes 46
Suicide risk and psychiatric comorbidity in patients with psoriasis 44
Long-term effectiveness and tolerability of apremilast in patients with moderate-to-severe plaque psoriasis: A 5-year multicentre retrospective study-IL PSO (Italian landscape psoriasis) 42
Real-life effectiveness of tildrakizumab in chronic plaque psoriasis: A 52-week multicentre retrospective study-IL PSO (Italian landscape psoriasis) 42
An 18-year follow-up of a case of D-penicillamine-induced Elastosis perforans serpiginosa 42
Noninvasive Assessment and Management of Folliculitis Decalvans by Trichoscopy and Reflectance Confocal Microscopy 40
Real-Life Effectiveness and Safety of Risankizumab in 131 Patients Affected by Moderate-to-Severe Plaque Psoriasis: A 52-Week Retrospective Study 38
Real-world evidence of biologic treatments in moderate-severe psoriasis in Italy: Results of the CANOVA (EffeCtiveness of biologic treAtmeNts for plaque psOriasis in Italy: An obserVAtional longitudinal study of real-life clinical practice) study 38
Anti-IL-23 and anti-IL-17 drugs for the treatment of non-pustular palmoplantar psoriasis: a real-life retrospective study 36
Upadacitinib 30 mg for the optimal management of moderate-to-severe atopic dermatitis: a 52-week single-center real-world study 36
What Can IBD Specialists Learn from IL-23 Trials in Dermatology? 36
Cutaneous toxicity of CAR T-cell therapy: Case report of a bullous life-threatening reaction 35
Pregnancy outcome of a patient treated with upadacitinib for severe atopic dermatitis 35
Pembrolizumab-induced plaque psoriasis successfully treated with risankizumab in a patient with stage IV cutaneous melanoma 35
Long-Term Effectiveness and Safety of Ixekizumab for the Treatment of Moderate-to-Severe Plaque Psoriasis: A Five-Year Multicenter Retrospective Study—IL PSO (Italian Landscape Psoriasis) 34
Bullous vasculitis associated with Streptococcus pyogenes sepsis 34
Brodalumab for the treatment of plaque psoriasis in a real-life setting: a 3 years multicenter retrospective study-IL PSO (Italian landscape psoriasis) 34
Fingertip dermatitis: a spy for psoriasis 34
Effectiveness and safety of bimekizumab for the treatment of plaque psoriasis: a real-life multicenter study-IL PSO (Italian landscape psoriasis) 33
An unusual case of annular bollous eruption of the inguinal folds 33
Real-Life Effectiveness and Safety of Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: A Single-Center 16-Week Study 32
A case of lichen amyloidosus treated with acitretin 32
Disseminated Superficial Porokeratosis with Dermal Amyloid Deposits 31
Biologics for the Treatment of Severe Acrodermatitis Continua of Hallopeau: Report of Two Cases Successfully Treated with Ixekizumab and Ustekinumab 31
A Case of Ketron-Goodman Disease 30
Intra-Class Switch Among IL-23 Inhibitors for Plaque Psoriasis: Is It Worth It? 30
Effectiveness and safety of upadacitinib for moderate‐to‐severe atopic dermatitis in a real‐world setting: A 52‐week retrospective study 29
Effectiveness of risankizumab in plaque psoriasis with involvement of difficult-to-treat areas: a real-world experience from two referral centers 29
Arrhythmias and other cardiovascular diseases in young patients (<40 years) with moderate/severe atopic dermatitis: A multicentric study in northern Italy 29
Skin cancers: how to balance the risks and benefits of surgery during COVID-19 pandemic (a Northern Italy single-center experience) 29
Anti-IL-17/23 Drugs for the Treatment of Moderate-to-Severe Hidradenitis Suppurativa in Patients With Concomitant Psoriasis: A Multicenter Retrospective Study 29
An updated safety review of Hidradenitis Suppurativa treatment options 28
Dupilumab for the treatment of atopic dermatitis of the elderly: a real-life 52-week experience 28
Real-life Effectiveness and Safety of Guselkumab in Moderate-to-Severe Plaque Psoriasis: A 104-Week Retrospective Single-Center Study 28
Sub-erythrodermic psoriasis successfully treated with bimekizumab: A case report 28
Clinical outcomes and management of JAK inhibitor-associated acne in patients with moderate-to-severe atopic dermatitis undergoing upadacitinib: A multicenter retrospective study 28
Angiomatoid lesions (leukocytoclastic vasculitis) as paraneoplastic manifestations of multiple myeloma IgA λ 27
Anti-interleukin-17 and anti-interleukin-23 biologic drugs for genital psoriasis: a single-center retrospective comparative study 27
A case of periocular contact dermatitis caused by cypress allergy 27
Tralokinumab rapidly improves subjective symptoms and quality of life in patients with moderate-to-severe atopic dermatitis: a real-life 16-week experience 27
Autoreactivity to self-antigens LL37 and ADAMTSL5 influences the clinical response to risankizumab in psoriatic patients 27
Safety of Biologic Therapies in Patients with Moderate-to-Severe Plaque Psoriasis and Concomitant Viral Hepatitis: A Monocentric Retrospective Study 27
Methotrexate-Induced Mucositis in a Patient With Angioimmunoblastic T-cell Lymphoma 27
Apremilast for the treatment of pustular psoriasis induced by neoadjuvant ifosfamide + etoposide chemotherapy for Ewing Sarcoma: a case report 27
Risankizumab for the treatment of genital psoriasis: A 1-year, real-world experience 26
Safety of anti-IL-23 drugs in patients with moderate-to-severe plaque psoriasis and previous tuberculosis infection: a monocentric retrospective study 26
Practical Use of Upadacitinib in Patients with Severe Atopic Dermatitis in a Real-World Setting: A Systematic Review 26
Daily Patient's Relief From Pruritus and Sleep Disturbance Over One-Month Treatment with Upadacitinib in Patients with Moderate-to-Severe Atopic Dermatitis: A Multicenter Prospective Study 26
Allergy to nickel: first results on patients administered with an oral hyposensitization therapy 26
Cutaneous manifestations of systemic non-Hodgkin lymphomas (NHL): study and review of literature 26
A Multidisciplinary Approach Is Beneficial in Atopic Dermatitis 26
Long-term management of pediatric psoriasis with ixekizumab: a case report 26
Optimizing Tildrakizumab Dosing in Psoriasis: A 52-Week Multicenter Retrospective Study Comparing 100 mg and 200 mg-IL PSO (Italian Landscape Psoriasis) 26
Drug survival of IL-12/23, IL-17 and IL-23 inhibitors for moderate-to-severe plaque psoriasis: a retrospective multicenter real-world experience on 5932 treatment courses – IL PSO (Italian landscape psoriasis) 25
Topical Pharmacological Treatment of Actinic Keratoses: Focus on Tirbanibulin 1% Ointment 25
Real-life effectiveness and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab: A 104-week multicenter retrospective study – IL PSO (ITALIAN LANDSCAPE PSORIASIS) 25
Comparative effectiveness of tildrakizumab 200 mg versus tildrakizumab 100 mg in psoriatic patients with high disease burden or above 90 kg of body weight: a 16-week multicenter retrospective study – IL PSO (Italian landscape psoriasis) 25
Cutaneous hypersensitivity to gluten 25
Real-life effectiveness and safety of dupilumab in adolescents with atopic dermatitis: a 52-week single-center retrospective study 25
Monkeypox infection with perianal lesions, fever, and lymphadenopathy 25
CD63 cell expression detected by flow-cytometric determination of basophil activation in allergic patients 24
Intra-class switch among interleukin-17 inhibitors for the treatment of plaque psoriasis: a single-center experience 24
A case of cutaneous large B-cell lymphoma of the legs appearing as chronic venous ulceration 24
Adalimumab-induced paradoxical pustular psoriasis and alopecia successfully treated with ixekizumab in a patient affected by hidradenitis suppurativa 24
Upadacitinib for the treatment of atopic dermatitis in the elderly: an Italian case series of seven patients 24
Efficacy and safety of JAK inhibitors in patients aged > 60 years with moderate-to-severe atopic dermatitis: a 52-week multicenter, real-life study-IL AD (Italian Landscape Atopic Dermatitis) 24
Totale 4.165
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.675
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.675
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021150 0 0 0 0 0 45 21 13 35 19 0 17
2021/2022154 2 0 5 31 1 0 9 21 13 17 46 9
2022/2023609 82 48 46 87 59 45 1 48 99 47 41 6
2023/2024623 25 49 126 27 15 60 60 66 16 20 64 95
2024/20251.334 15 22 19 18 8 111 94 68 170 242 215 352
2025/20262.876 692 409 542 859 297 77 0 0 0 0 0 0
Totale 5.754